IDEX BIOMETRICS ASA (IDEX.OL) Stock Earnings & Estimates
Europe - Euronext Oslo - OSL:IDEX - NO0013536078 - Common Stock
6.3 NOK
-0.5 (-7.35%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|
| Revenue YoY % growth | 4.091M 44.05% | 4.138M 1.15% | 841K -79.68% | 1.102B | |
| EBITDA YoY % growth | -30.017M -1.59% | -25.212M 16.01% | -19.386M 23.11% | 191.56M | |
| EBIT YoY % growth | -31.369M -0.06% | -26.847M 14.42% | -21.903M 18.42% | 174.24M | |
| Operating Margin | -766.78% | -648.79% | -2,604.40% | 15.81% | |
| EPS YoY % growth | N/A | -90.65 21.17% | N/A 100.00% | 0.52 |
Reported data in USD, estimates in NOK
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.07 -250.00% | % | ||
| Q4 2024 Q2Q % growth | 0.00 100.00% | % | ||
| Q2 2024 Q2Q % growth | -0.02 99.96% | % | ||
| Q4 2023 Q2Q % growth | -0.02 | -0.05 | 0.03 | 56.30% |
| Q3 2023 Q2Q % growth | -0.01 | -4.12 | 4.11 | 99.76% |
| Q2 2023 Q2Q % growth | -46.39 | -1,786.34 | 1,739.95 | 97.40% |
| Q1 2023 Q2Q % growth | -44.23 | -1,877.95 | 1,833.72 | 97.65% |
| Q4 2022 Q2Q % growth | 0.00 100.00% | % | ||
| Q4 2021 Q2Q % growth | -0.02 77.78% | % | ||
| Q2 2021 Q2Q % growth | -0.01 88.51% | % | ||
| Q1 2021 Q2Q % growth | -0.09 -1.19% | % |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are NOK.
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 80K -79.49% | % | ||
| Q1 2025 Q2Q % growth | 104K -72.04% | % | ||
| Q4 2024 Q2Q % growth | 20K -95.83% | % | ||
| Q3 2024 Q2Q % growth | 60K -93.68% | % | ||
| Q2 2024 Q2Q % growth | 390K -97.51% | % | ||
| Q1 2024 Q2Q % growth | 372K -97.07% | % | ||
| Q4 2023 Q2Q % growth | 480K -54.97% | 11.442M | -10.962M | -95.80% |
| Q3 2023 Q2Q % growth | 950K 2.37% | 21.128M | -20.178M | -95.50% |
| Q2 2023 Q2Q % growth | 15.656M 1,313.00% | 19.015M | -3.359M | -17.67% |
| Q1 2023 Q2Q % growth | 12.709M 1,185.04% | 15.846M | -3.137M | -19.80% |
| Q4 2022 Q2Q % growth | 1.066M 35.45% | % | ||
| Q3 2022 Q2Q % growth | 928K 26.78% | % | ||
| Q2 2022 Q2Q % growth | 1.108M 58.97% | % | ||
| Q1 2022 Q2Q % growth | 989K 58.49% | % | ||
| Q4 2021 Q2Q % growth | 787K 31.61% | % | ||
| Q3 2021 Q2Q % growth | 732K 195.16% | % | ||
| Q2 2021 Q2Q % growth | 697K 367.79% | % | ||
| Q1 2021 Q2Q % growth | 624K 524.00% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 0% |
| Revenue | N/A | N/A | 0% | 0% |